Tag: Therapeutics
Lupin Digital Health introduces Digital Therapeutics Certificate for Cardiologists
This collaboration is crucial in ensuring top-notch care and enhancing outcomes, all from the convenience of patients' homes
CSIR-CDRI collaborates with Bengaluru based startup to develop novel therapeutics for...
The collaboration will entail the use of advanced artificial intelligence and computational tools developed at Sravathi AI to design novel chemical entities (NCEs) with anti-cancer properties
Ultragenyx’s UX053 Phase I/II study termination a minor setback for mRNA...
The study was terminated due to reasons unrelated to safety concerns, although the specific rationale has not been disclosed by the biopharmaceutical company
UW-Madison Global Health Institute partners Ella Foundation to establish first-ever ‘UW-Madison...
Partnership expands the Wisconsin Idea by providing interdisciplinary collaborations with UW-Madison, the Ella Foundation, and Bharat Biotech
US subsidiary of Zydus Lifesciences buys BridgeBio Pharma’s NULIBRY
NULIBRY is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
A painkiller that doesn’t hurt!
An international research team has examined the therapeutic and adverse effects of a newly synthesized potentially safer compound with anti-inflammatory and analgesic properties, opening doors to novel drugs for patients in need
Indian scientists develop new compound to treat Autism
Researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have developed a compound that has demonstrated a potential to restore neuronal function, learning and memory, and reduce epileptic seizures in a mouse model.................
Aragen partners Skyhawk Therapeutics to develop novel molecules that correct RNA...
Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions.....................
IISER Bhopal scientists invent technology for precision protein engineering
The platform will help Cancer patients with precise imaging-guided tumor surgeries and directed Cancer Chemotherapeutics in the coming years.........................
Genomics-guided approach for development of a therapeutic decoy-trap for COVID-19 treatment
A new study has analyzed genetic variation in ACE2, the receptor for the COVID-19 causing SARS-CoV-2 virus, from over 300,000 individuals and identified key mutations that are predicted to make individuals more susceptible to the virus....................